Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?

Ronald de Wit, M Aapro, PR Blower

Research output: Contribution to journalArticleAcademicpeer-review

33 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)231-238
Number of pages8
JournalCancer Chemotherapy & Pharmacology
Issue number3
Publication statusPublished - 2005

Research programs

  • EMC MM-03-86-08
  • EMC OR-01-86-13

Cite this